Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...
Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...
Moderna Inc's experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage ...
Once-daily oral GLP-1 drug orforglipron leads to significant, dose-dependent weight loss and metabolic benefits without diabetes.
Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-COVID-19 formulations as the world's largest producer of vaccines prepares for a massive response to ...
The estimated effectiveness of last year's COVID-19 vaccine among US veterans was 29% against related emergency department ...
Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...
Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...
President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...
Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results